ACSL1 Inhibits ALV-J Replication by IFN-Ⅰ Signaling and PI3K/Akt Pathway

J subgroup avian leukosis virus (ALV-J) infection causes serious immunosuppression problems, leading to hematopoietic malignancy tumors in chicken. It has been demonstrated that interferon-stimulated genes (ISGs) could limit ALV-J replication; nevertheless, the underlying mechanisms remain obscure. Here, we demonstrate that Long-chain Acyl-CoA synthetase 1 (ACSL1) is an interferon (IFN)-stimulated gene that specifically restricts the replication of ALV-J due to the higher IFN-I production. More importantly, ACSL1 induces primary monocyte-derived macrophages (MDMs) to pro-inflammatory phenotypic states during ALV-J infection, and ACSL1 mediates apoptosis through the PI3K/Akt signaling pathway in ALV-J-infected primary monocyte-derived macrophages (MDMs). Overall, these results provide evidence that ACSL1 contributes to the antiviral response against ALV-J.


INTRODUCTION
J subgroup avian leukosis virus (ALV-J) is an alpharetro virus that mainly induces hematopoietic malignancy with myeloid leukemia in chicken (1,2). ALV-J infection is closely related to the onset of visceral and vascular neoplasms with associated adverse consequences, including stunted growth, decreased egg production, and increased mortality, causing significant economic loss for the poultry industry worldwide (3,4). Unfortunately, no vaccines or drugs have been exploited to treat the ALV-J infection-triggered disease effectively (5). The innate immune system is the first line of host defense against pathogen invasion (6). One of the most potent events is the activation of interferon (IFN) pathways (7). When IFNs bind to their receptors, a cascade of signals gets activated, resulting in the activation of several IFN-stimulated genes (ISGs). Indeed, the ISGs play crucial roles and exert diverse functions at multiple levels of antiviral immunity. For instance, the interferon-induced transmembrane (IFITM) family blocks virus replication by inhibiting the virus and host cell membrane fusion (8), the zinc-finger antiviral protein (ZAP) binds to the target RNA to block the translation of viral mRNA (9), and the IFNinduced protein with tetratricopeptide repeats 5 (IFIT5) inhibits RNA virus replication by preventing virus translation and initiating innate immunity (10,11). Notably, in our previous study, we proved that the ALV-J can be particularly sensitive to IFN-I (12). Moreover, previous studies have demonstrated that overexpression of the immune response gene 1 (IRG1), 2,5oligoadenylate synthetase (2,, and cholesterol-25hydroxylase (CH25H) could significantly decrease ALV-J replication in vitro (12,13). Despite lots of ISGs have been identified in chicken, the functions of the majority of individual ISGs and precisely how they inhibit replication of ALV-J remain unclear.
Long-chain Acyl-CoA synthetase 1 (ACSL1), a member of the ACSLs family, is responsible for the activation of the most abundant long-chain fatty acids (12-22 carbons) (14,15). The lipid metabolism network is extensive and intertwined, involving various metabolic functions such as energy production, temperature regulation, and molecular signal synthesis (16,17). However, deregulated fatty acid metabolism favoring excess lipid biosynthesis and deposition eventually predispose the disease occurrence, such as cardiovascular diseases, metabolic diseases, and cancer (18). Increasing studies support that ACSL1 is deregulated in clinical cancer. For example, ACSL1 is reported to be upregulated in colorectal (19), breast cancer (20), and myeloma (21), while downregulation is found in liver, non-small-cell lung, and blood cancer (19). Interestingly, ACSL1 is induced by Gram-negative bacteria, lipopolysaccharide (LPS) and IFN-g, and tumor necrosis factor-a (TNF-a) (22). Thus, ACSL1 may have an important role in cancer and the innate immune response. Notably, we have analyzed previously published in vitro transcription-sequencing data of ALV-J and IFN-a cotreatment chicken peripheral blood mononuclear cells (PBMCs) and identified ACSL1 as an ISG (12). Thus, we speculate that ACSL1 could be an important ISG to influence ALV-J replication. However, the role and potential mechanism of ACSL1in ALV-J replication is still unknown.
Therefore, in the present study, we investigate the role of ACSL1 in ALV-J replication. Through exogenous expression and small interfering RNA (siRNA) knockdown, we find that ACSL1 inhibits ALV-J replication by enhancing IFN-I production. Further studies demonstrate that ACSL1 induces apoptosis via the PI3K/Akt signaling pathway and promotes inflammation in ALV-J-infected primary monocyte-derived macrophages (MDMs). Our results not only reveal the mechanism by which ACSL1 inhibits ALV-J replication, but also extend understanding of the host's innate immunity to ALV-J infection.

Animals, Virus, and Cells
A total of specific-pathogen-free (SPF) White Leghorn chickens were purchased from Guangdong DaHuaNong Animal Health Products Co., Ltd (Guangzhou, China) and housed under pathogen-free conditions. ALV-J strain SCAU-HN06 was kindly provided by Prof. Weisheng Cao, South China Agricultural University. A 10 4 TCID 50 /0.1 ml of ALV-J SCAU-HN06 were used in this study. DF-1 cells were purchased from the American Type Culture Collection. Chicken primary MDMs were cultured and identified according to previous studies (23,24).

Cell Culture and Virus Infection
DF-1 cells were cultured in DMEM (Catalogue number:11995065, Gibco), supplemented with 10% FBS, and maintained at 37°C and 5% CO2. MDMs were cultured in RPMI-1640 medium with 15% chicken serum, 100 U/ml penicillin, and 100 mg/ml streptomycin and maintained at 37°C and 5% CO 2 . For the cells being infected with virus, briefly, DF-1 cells or MDMs were infected with ALV-J strain SCAU-HN06 (10 4 TCID 50 /0.1 ml) in without DMEM for 2 h, washed by 1×PBS, and incubated with fresh complete medium for the times shown in the figures.
instrument (Bio-Rad) with SYBR green fast mixture (Bio-Rad) was used for quantitative real-time PCR analysis. Expression levels were quantified using the 2 −DDCt method and normalized to GAPDH. The primer sequences are listed in Supplementary  Table 1. The concentrations of IFN-a, IFN-b, IL-1b, and IL-18 in culture supernatants were measured using kits from R&D Systems, according to the manufacturer's instructions.
Detection of NO, ATP, Mitochondrial Membrane Potential JC1, and Mitochondrial Respiratory Chain Enzymes Total Nitric Oxide assay kit (Beyotime Biotechnology, Shanghai, China) was used to analyze the levels of NO production in MDMs, according to the manufacturer's instructions. The concentration of nitrite was measured using absorbance readings at 540 nm. The levels of ATP were detected using the Enhanced ATP assay kit (Beyotime Biotechnology, Shanghai, China), according to the manufacturer's instructions. The luminous value of ATP was read in Luminometer. Enhanced mitochondrial membrane potential assay kit (Beyotime Biotechnology, Shanghai, China) with JC-1 was used to analyze the levels of JC1 in MDMs. For detection with fluorescence microplate reader, excitation wavelength was 485 nm and emission wavelength was 590 nm. The activities of the mitochondrial complex I or IV were determined by the Mitochondrial Respiratory Chain Complex I or IV activity assay kit (Solarbio, Beijing, China) according to the manufacturer's instructions. Briefly, mitochondrial homogenates were added into the respective reaction buffer. The reaction mixture was transferred to a microtiter plate and immediately put into a microplate reader (Thermo Fisher). The absorbance of reaction mixture was measured at 340 nm for Complex I and 550 nm for Complex IV, respectively. Mitochondrial complex activity was expressed as nmol/min/mg protein.

Caspase-1, Caspase-3, and Caspase-8 Activity Assays
Caspase activity assay kits were used to detect the activity of caspases, according to the manufacturer's instructions. Briefly, cell lysates were centrifuged at 13,000 g, 4°C, for 15 min, and the protein concentrations were determined by Bradford protein assay (Beyotime Biotechnology, Shanghai, China). Protein extracts were incubated with reagent from caspases activities kit in a 96-well microtiter plate at 37°C, for 2 h or overnight and detected at a wavelength of 405 nm using a MultiScan Go microplate reader (Thermo Fisher Scientific, Inc.).

Western Blotting
Total proteins were extracted using IP cell lysate buffer with 1 mM PMSF. Proteins were resolved using SDS-polyacrylamide gel electrophoresis (4-15% SDS-PAGE) and transferred onto methanol-activated polyvinylidene difluoride (PVDF) membrane (Bio-Rad). The membranes were incubated with the aforementioned primary antibodies (1:1,000). Protein bands were visualized using a C600 ultrasensitive chemiluminescence imager, and expression levels were quantified using Image-Pro Plus software. The membrane-developed blots were developed, observed, and analyzed by using AlphaImager 2200 software (Alpha Innotech Corporation, CA, USA).

Luciferase Reporter Gene Assay
The promoter region of ACSL1 (−1 to −2,112 bp, −1 to −1,584bp, −1 to −1014 bp, −1 to −527 bp, −1 to −281 bp) was cloned into the pGL3-basic vector. DF-1 cells were plated at a density of 10 5 cells per well in a 48-well plate. DF-1 cells were transiently transfected with 100 ng ACSL1 promoter-luciferase reporter vectors and 5 ng Renilla luciferase reporter vectors plus Flag-STAT1, IRF1 expressing plasmids using Lipofectamine 3000. After 24 h, cells were harvested and luciferase activities were measured with a dual-luciferase reporter assay system (Promega) according to the manufacturer's instructions. Data are normalized for transfection efficiency by dividing Firefly luciferase activity by Renilla luciferase activity. Each experiment was replicated at least three times.

Flow Cytometry
The prepared cells were added to 500 ml 1× Annexin V buffer, and the cells were gently resuspend. Cell suspensions were incubated with 5 ml Annexin V-FITC and 5 ml propidium iodide staining solution at 25°C for 15 min in the dark and then detected by flow cytometry.

Confocal Microscopy
DF-1 cells were transfected with the expression plasmid for Flagtagged ACSL1. After 24 h, cells were ALV-J infected or IFN-a treated for 16 h. The cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% saponin, then blocked for 30 min with 10% skim milk, incubated overnight at 4°C with anti-Flag primary antibody. Cells were incubated with corresponding FITC-labeled secondary antibodies, and DAPI were used to stain the nucleus. Imaging of the cells was carried out using Leica TCS SP5 confocal laser microscopy under a ×40 objective.

Statistical Analysis
Statistical comparisons were performed using GraphPad Prism (version 8.0) software (GraphPad Software Inc.). Student's t test was used to analyze the data. Data shown are the means ± SEM. Differences with p < 0.05 were considered significant. *P < 0.05, **P < 0.01, ***P < 0.001.

Promoter Region and Phylogenetic Analysis of ACSL1
To identify which nucleotides and regions are important in determining ACSL1 transcription, the 2,112 bp nucleotide sequences upstream of the ACSL1 coding region were truncated into five segments to construct different dualluciferase reporter vectors. Luciferase reporter assays revealed that there were five abnormal fluctuations in ACSL1 promoter region (Supplementary Figure 1A). Using the promoter prediction server (http://alggen.lsi.upc.es/), IRF1 and STAT1 as transcription factors were found in between −1,584 and −1,014 bp of ACSL1 promoter region (Supplementary Figure 1B). Based on these analyses, we constructed ACSL1 promoter reporter which contained the region between −1,584 and −1,014 bp (wt P3-P4-luc) and a mutated reporter (mt P3-P4luc) construct with mutation of the IRF1 and STAT1 binding motifs. Then, ACSL1 promoter reporter (wt P3-P4-luc) or its mutation (mt P3-P4-luc) were co-transfected with IRF1 or STAT1 expression plasmids into chicken embryo fibroblast cell lines (DF-1 cells). The luciferase reporter assays showed that when co-transfected with IRF1 or STAT1, the fluorescence intensity value was increased in wt P3-P4-luc cells compared to mutation group (Supplementary Figures 1C, D). Thus, these findings suggest that IRF1 and STAT1 might be transcription factors, driving ACSL1 transcription in the IFN-I signaling pathway. Moreover, to identify the sequence characteristics of the chicken ACSL1, phylogenetic analyses of the relationship between ACSL1 sequence of different species were performed, and the result showed that the chicken ACSL1 most closely to the ring-necked pheasant and the turkey (Supplementary Figure 1E).

ALV-J Infection Induces ACSL1 Expression
To identify whether ACSL1 was an ISG, we examined the levels of ACSL1 in DF-1 cells or MDMs infected with ALV-J or stimulated with IFN-a. We found that ACSL1 was significantly induced upon ALV-J infection in DF-1 cells ( Figure 1A) or IFNa stimulation in MDMs ( Figure 1B). It has been reported that ALV-J infection induces strong innate immune responses in MDMs at the early infection stage, instead of the late infection stage (13,23). Expectedly, upon ALV-J infection, mRNA levels of ACSL1 in MDMs were significantly decreased by 24 h postinfection (hpi) ( Figure 1B). Subsequently, we investigated the localization of ACSL1 in cells. We firstly overexpressed Flag-ACSL1 in DF-1 cells and then infected them with ALV-J (10 4 TCID 50 /0.1 ml) or stimulated with alpha IFN (IFN-a, . P values were calculated using two-tailed unpaired Student' t-test. Differences with p < 0.05 were considered significant. *P < 0.05, **P < 0.01, ***P < 0.001. 1,000 U/ml). The result of immunofluorescence assay showed that ACSL1 was vividly located in the nucleus ( Figure 1C). Interestingly, ACSL1 was observed in the cytoplasm and nucleus after being infected with ALV-J or treated with IFN-a ( Figure 1C), suggesting that ALV-J or IFN-a regulates the localization of ACSL1. Moreover, the abundance of ACSL1 in chicken liver and bone marrow and the upregulation in immunerelated tissues including kidney and spleen after intraperitoneal injection of ALV-J were also observed by quantitative RT-PCR (qRT-PCR) (Figures 1D, E). Collectively, ACSL1 is an ISG which could be upregulated upon ALV-J infection and IFNa treatment.

ACSL1 Limits ALV-J Replication by Inducing IFN-Ⅰ Production
To understand the function of ACSL1 during ALV-J infection, DF-1 cells were transfected with ACSL1 expression plasmid or small interfering RNA (siACSL1 or si-control) followed by ALV-J infection. The result of qRT-PCR and immunoblot analyses showed that the level of ALV-J was significantly decreased in cells overexpressing ACSL1 compared to empty vector control (Figures 2A, B), while the level of virus was greatly increased in cells transfected with siACSL1 ( Figures 2C, D). Next, we sought to determine if ACSL1 suppresses ALV-J by affecting the level of IFN-I. Interestingly, we found that the levels of IFN-a/IFN-b in cells overexpressing ACSL1 were higher than that in control cells with ALV-J infection ( Figure 2E). Consistently, the same results were confirmed in the qRT-PCR ( Figure 2F). In contrast, when ACSL1 was knocked down in cells, the levels of IFN-a/IFN-b were both significantly decreased ( Figures 2G, H). Meanwhile, mRNA expression of some ISGs, including OAS, ZC3HAV1, and Mx, was increased when ACSL1 was overexpressed in DF-1 cells, but reduced in the absence of ACSL1, whereas PKR was no significant difference ( Figures 2I, J). Next, we found that the phosphorylation of STAT1 in cells overexpressing ACSL1 upon ALV-J infection was higher in comparison to the control cells ( Figure 2B), suggesting that JAK/STAT signaling might be activated, which in turn enhances the expression of ISGs. Subsequently, we further evaluated the impact of ACSL1 on the antiviral efficiency of IFN-a against ALV-J. The result showed that IFN-a pretreatment reduced viral production in both groups; however, it was less efficient in protecting ACSL1 knockdown cells against ALV-J replication as compared to the control cells ( Figure 2K). Taken together, our findings suggest that ACSL1 is involved in inhibiting ALV-J replication by positively regulating type IFN-I production.

ACSL1 Inhibits ALV-J Replication by Affecting the Activation of Akt
A previous study found that ALV-J infection was discovered to activate the phosphorylation of Akt (25). We had identified ACSL1 as an inhibitor that might target the activation of Akt using the KEGG database (www.genome.jp/pathway/hsa04920+2180) (Supplementary Figure 2). Thus, we assumed that ACSL1 inhibits ALV-J replication by affecting the activation of Akt. To verify this hypothesis, we first overexpressed ACSL1 in DF-1 cells prior to infection with ALV-J and then performed immunoblot assays. As expected, the phosphorylation of Akt in overexpressed ACSL1 cells was significantly decreased (Figures 3A-C).
In contrast, knockdown of ACSL1 increased the phosphorylation of Akt (Figures 3D-F). Next, a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, was pretreated in ACSL1 knockdown cells for 1 h and then infected with ALV-J ( Figure 3G). The result showed that the level of ALV-J was significantly decreased in ACSL1 knockdown cells with LY294002 pretreatment (Figures 3G-I). Collectively, these data suggest that ACSL1 inhibits ALV-J replication through decreasing the phosphorylation of Akt.

ACSL1 Induces Apoptosis Through PI3K/Akt Signaling Pathway in MDMs During ALV-J Infection
Phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/ Akt) signaling pathway is responsible for regulating cell survival (26). A previous study found that ALV-J infection can induce chicken monocyte apoptosis (27). Thus, we hypothesized that ACSL1 induces apoptosis via the PI3K/Akt signaling pathway, which in turn affects ALV-J replication. To test this hypothesis, we performed flow cytometry analysis of apoptosis in MDMs which were overexpressed or knockdown ACSL1 followed by infecting with ALV-J. The result showed that the apoptosis was significantly increased in MDMs overexpressing ACSL1 compared to empty vector control ( Figure 4A and Supplementary Figures 3A, B). In contrast, when siACSL1 was transfected in MDMs, the apoptosis was significantly decreased ( Figure 4B and Supplementary Figures 3C, D). Subsequently, the expression levels of apoptosis-related genes in the PI3K/Akt signaling pathway were analyzed using immunoblot and qRT-PCR. Compared with the control cells, the levels of phosphorylated Akt were markedly decreased, while the levels of phosphorylated IKK were increased in MDMs overexpressing ACSL1 (Figures 4C, D). When in ACSL1 knockdown cells, the results have been reversed verified ( Figures 4E, F). Moreover, the mRNA expression of these relative genes was significantly upregulated in MDMs overexpressing ACSL1 compared to empty vector control, including AIF, CYCS, and FKHR, while caspase-9 was not significantly different ( Figure 4G). Similarly, the opposite results have been verified in ACSL1 knockdown cells ( Figure 4H). Overall, the above evidence supports that ACSL1 inhibited ALV-J replication via the PI3K/Akt signaling pathwayinduced apoptosis.
Considering activated caspase-1 can mediate proteolytic cleavage of the pro-inflammatory precursor cytokines prointerleukin-1b (IL-1b) and pro-IL-18 (31,32), we further examined the levels of IL-1b and IL-18 in MDMs with ACSL1 overexpression or knockdown upon ALV-J infection. The results of qRT-PCR and ELISA analyses showed that the levels of IL-1b and IL-18 were significantly increased in ACSL1 overexpressed cells, while were decreased in ACSL1 knockdown cells ( Figures 5G-J and Supplementary Figures 4G-J). Moreover, we found that the levels of nitric oxide (NO) and inducible nitric oxide synthase (iNOS) in overexpressed ACSL1 cells were remarkably increased. Conversely, the opposite results have been verified in ACSL1 knockdown cells ( Figures 5K, L and Supplementary Figures 4K, L). Together, these findings prove that ACSL1 may enhance inflammation to fight against ALV-J infection in MDMs.

ACSL1 Induces MDMs to Pro-Inflammatory Phenotypic States During ALV-J Infection
It has long been known that macrophages can be driven to specific states of activation following exposure to defined environmental cues and cytokines (33). So, we suspected that ACSL1 would change the functional states of MDMs for inhibiting ALV-J replication. We have confirmed ACSL1 enhanced the antiviral functions of MDMs, including upregulation of the levels of IL-1b and IL-18, and induced the production of NO (Figures 5G-L). Next, we examined the levels of triphosphate (ATP) and mitochondrial membrane potential JC1. The results showed that upon infection, the levels of ATP and JC1 were decreased in MDMs overexpressing ACSL1, while were increased in ACSL1 knockdown cells (Figures 6A-D). The levels of JC1 were decreased, meaning there was occurrence of early apoptosis in MDMs.
Due to changes in the levels of ATP, we speculate that the activity of mitochondrial respiratory chain enzymes will also change accordingly. The activities of mitochondrial respiratory chain complexes I, II, and III were all reduced to varying degrees in MDMs overexpressing ACSL1 (Figures 6E-H). When in ACSL1 knockdown cells, the activities of mitochondrial respiratory chain complexes all showed increased (Figures 6I-L). These results suggest that ACSL1 induces MDMs to pro-inflammatory phenotypic states, which in turn enhances the antiviral response. The experiments were repeated three times, independently, with similar results obtained. Data shown are the means ± SEM (n=3). P values were calculated using two-tailed unpaired Student' t-test. Differences with P < 0.05 were considered significant. ***P < 0.001.

DISCUSSION
The main reason for the difficulty in vaccine or drugs development of ALV-J is the genetic instability and variability of the retrovirus. Severe economic losses caused by ALV-J remain an unsolved problem in the world due to inefficient eradication strategies and lack of effective vaccines (34). IFN-I is the important element in provoking the host innate immunity system against viruses. Although ALV-J can be sensitive to IFN-I-induced inhibition (12), the specific ISGs that mediate the anti-ALV-J activity of . P values were calculated using two-tailed unpaired Student's t-test. Differences with P < 0.05 were considered significant. *P < 0.05, **P < 0.01, ***P < 0.001. . P values were calculated using two-tailed unpaired Student's t-test. Differences with P < 0.05 were considered significant. *P < 0.05, **P < 0.01, ***P < 0.001.

IFNs
have not yet been fully defined. Here, we have demonstrated that one ISG, ACSL1, can restrict the replication of ALV-J by positively regulating type IFN-I production, and induce apoptosis via the PI3K/Akt signaling pathway. In addition, ACSL1 activates MDMs to pro-inflammatory phenotypic states during ALV-J infection (Figure 7). In this study, we found that ACSL1 has various function during ALV-J infection. We observed that ACSL1 inhibiting ALV-J replication is largely due to the higher IFN-I production. IFNs induce activation of the JAK/STAT signaling pathway, which in turn stimulate the transcription of ISGs (35). As expected, the phosphorylation of STAT1 and some ISGs was significantly increased after ACSL1 overexpression. Therefore, it suggested that the relationship between ACSL1 and IFN may be positive feedback regulated. Unfortunately, the detailed mechanism of how ACSL1 promotes IFN-I is unknown in this study.
Specifically, upon ALV-J infection, ACSL1 promotes apoptosis via the PI3K/Akt signaling pathway and induces an increase in inflammation. Viruses regulating the activation of signaling pathway is one of the effective means to promote their survival or aid their infection at different stages of the viral life cycle (36). Activation of the PI3K/Akt signaling pathway is one of the early infection events of ALV-J (25), while PI3K/Akt signaling pathway plays an important role in proliferation and apoptosis (37). After the detection of the levels of apoptosis-related genes, we found that ACSL1 triggers apoptosis through the PI3K/Akt signaling pathway. Likewise, upon ALV-J infection, we also observed that the activation of apoptosis-related proteins caspase-1, caspase-3, and caspase-8 is increased in ACSL1-overexpressed cells. The activation of caspase-1 leads to the release of inflammatory hallmarks IL-1b and IL-18 (28). As anticipated, we found that ACSL1 overexpression elevates levels of pro-inflammatory cytokines, including IL-1b and IL-18. IL-1b is a potent inducer of inflammation, vasodilation, and immune cell extravasation (38). IL-18 promotes IFN-g production in TH1 cells, NK cells, and cytotoxic T cells, enhancing the development of TH2 cells and promoting local inflammation (39). Moreover, IL-1b and IL-18 as pro-inflammatory cytokines prevent the infection of pathogens effectively, yet excess pro-inflammatory cytokines is harmful to the host. Importantly, although apoptosis has generally been considered an immunologically silent process, emerging evidence indicates that apoptosis can be inflammatory when induced under certain conditions and has roles in the host defense against infection (40)(41)(42). In the present study, our results prove the above point of view. The in vivo reality is of much greater nuance and complexity, so further research on this aspect is needed in vivo.
In addition to the abovementioned data, we were pleasantly surprised to find that ACSL1 induces MDMs to pro-inflammatory phenotypic states during ALV-J infection. Similar to M1-like macrophages polarization states (43), ACSL1 overexpressing MDMs show enhanced microbicidal responses, including production of inflammatory, generation of NO, change of ATP, JC1, and mitochondrial respiratory chain complexes. Currently, there are relatively few descriptions about ISG changes in the phenotypic or metabolic function of macrophages, thus whether and how ISGs shape macrophage polarization that affect pathogen infection remains an open question.
In summary, we have identified a novel ISG, ACSL1, that is important to inhibit ALV-J replication. Inhibition of virus replication in a host population can significantly reduce the change of viral adaption (44). The availability of genome-editing tools, notably CRISPR/Cas9, widens the scope of animal breeding and its applications in the context of disease control, while targeted genome editing has been proven useful to resistant ALV-J in chickens (34,44,45). In this context, exploiting more antiviral genes are particularly valuable in chickens. Thus, our work not only polishes our knowledge about the immune response strategies between the host and ALV-J but also provides valuable targets for gene-engineering or treating ALV-J infection-triggered diseases.

DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

ETHICS STATEMENT
The animal study was reviewed and approved by South China Agricultural University. Written informed consent was obtained FIGURE 7 | Schematic map of ACSL1 regulating ALV-J replication. ACSL1 positively regulates type IFN-I production, induces apoptosis via the PI3K/Akt signaling pathway, and promotes inflammation, which in turn inhibits ALV-J replication. IFNAR, interferon receptors; ISGs, interferon stimulate genes. from the owners for the participation of their animals in this study.

AUTHOR CONTRIBUTIONS
QZ conceived and performed the experiments, analyzed the data, and wrote the manuscript. TX and GM conceived the experiments and revised the manuscript. ZZ and LL analyzed data and assisted in the cell culture work. XZ revised and approved the final manuscript. All authors contributed to the article and approved the submitted version.